$2.18
-0.07 (-3.11%)
DURECT Corp (DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

RSS Headlines
Fool UK